Gagnon E

Title : Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study - Gagnon_2025_Circ.Genom.Precis.Med__e004933

Author(s) : Gagnon E , Gill D , Chabot D , Cronje HT , Yuan S , Brennan S , Theriault S , Burgess S , Arsenault BJ , Dib MJ

Ref : Circ Genom Precis Med , :e004933 , 2025

Abstract :

PubMedSearch : Gagnon_2025_Circ.Genom.Precis.Med__e004933

PubMedID: 40052268

Title : Impact of loss-of-function in angiopoietin-like 4 on the human phenome - Gagnon_2024_Atherosclerosis_393_117558

Author(s) : Gagnon E , Bourgault J , Gobeil , Theriault S , Arsenault BJ

Ref : Atherosclerosis , 393 :117558 , 2024

Abstract :

PubMedSearch : Gagnon_2024_Atherosclerosis_393_117558

PubMedID: 38703417

Gagnon E

References (2)

1. Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study - Gagnon_2025_Circ.Genom.Precis.Med__e004933

2. Impact of loss-of-function in angiopoietin-like 4 on the human phenome - Gagnon_2024_Atherosclerosis_393_117558